| For: | Horowitz M, Cai L, Islam MS. Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwards. World J Diabetes 2024; 15(3): 326-330 [PMID: 38591090 DOI: 10.4239/wjd.v15.i3.326] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i3/326.htm |
| Number | Citing Articles |
| 1 |
Zeyad Elawa, Ahmed Khalil, Ahmed Kardousha, Ahmed ElAwwa, Ashraf T. Soliman. GLP-1 receptor agonists and surgical care: implications for bariatric Procedures, perioperative Outcomes, and nutritional optimization. Diabetes Research and Clinical Practice 2026; 237 doi: 10.1016/j.diabres.2026.113332
|
| 2 |
Simona Di Martino, Maria De Rosa. Peptide-based therapeutics targeting GPCRs: recent applications in the treatment of metabolic disorders. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1930768
|
| 3 |
Jiayu Yan, Minyue Cao, Yan Ding, Yiqin Zhang, Yihan Sun, Genyi Jiang, Yanli Zhang, Luyao Kang, Xue Zhou, Jing Luo, Bilan Li. The Role and Mechanism of Incretins in Gynaecologic Diseases. Endocrinology, Diabetes & Metabolism 2026; 9(5) doi: 10.1002/edm2.70340
|